Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUAN C GARZA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1669449971
CMS profile
165973
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,514.63

68 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,514.63 68

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 68 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUAN C GARZA

NPI 1669449971 · CMS profile ID 165973

Allopathic & Osteopathic Physicians / Family Medicine

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 68 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669449971?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUAN C GARZA, NPI 1669449971, CMS profile ID 165973. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 68 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669449971?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JUAN C GARZA, NPI 1669449971, CMS profile ID 165973. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 68 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669449971?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JUAN C GARZA, NPI 1669449971, CMS profile ID 165973, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 68 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1669449971?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

68 matching records · $1,514.63 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 68 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 68.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $10.0712/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949507289 CMS
PFIZER INC. $3.5412/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949541515 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.5912/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955640989 CMS
Biohaven Pharmaceutical Holding Company Ltd. $15.8812/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923596015 CMS
Bayer HealthCare Pharmaceuticals Inc. $17.9612/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930078859 CMS
Merz North America, Inc. $300.0011/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950339293 CMS
Novo Nordisk Inc $15.3411/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898996233 CMS
Teva Pharmaceuticals USA, Inc. $24.2511/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954830589 CMS
Novo Nordisk Inc $23.3611/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898996241 CMS
GlaxoSmithKline, LLC. $23.4211/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944863111 CMS
GlaxoSmithKline, LLC. $11.7310/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944863109 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.5810/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955640987 CMS
ABBVIE INC. $12.6110/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891010991 CMS
AstraZeneca Pharmaceuticals LP $17.0210/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914755317 CMS
Biohaven Pharmaceutical Holding Company Ltd. $27.0610/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923596013 CMS
Bayer HealthCare Pharmaceuticals Inc. $21.5910/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930097621 CMS
Novo Nordisk Inc $19.2809/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899043721 CMS
PFIZER INC. $5.9209/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949341553 CMS
Lilly USA, LLC $14.8309/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918171923 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.3409/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887675631 CMS
Novo Nordisk Inc $2.5408/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898619215 CMS
Novo Nordisk Inc $3.1508/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898619234 CMS
Kite Pharma, Inc. $14.2408/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920063363 CMS
Biohaven Pharmaceutical Holding Company Ltd. $20.7108/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923596011 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.6208/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955640985 CMS
Ironwood Pharmaceuticals, Inc $34.9608/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957911805 CMS
AstraZeneca Pharmaceuticals LP $19.7607/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914852561 CMS
Bayer HealthCare Pharmaceuticals Inc. $19.5907/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929963979 CMS
ABBVIE INC. $10.9207/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891010989 CMS
Novo Nordisk Inc $14.5807/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898619249 CMS
Novo Nordisk Inc $12.2707/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898619241 CMS
Biohaven Pharmaceutical Holding Company Ltd. $22.7907/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923596009 CMS
Lilly USA, LLC $12.8706/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918149841 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.9806/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930097569 CMS
Amarin Pharma Inc. $14.7406/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 913916249 CMS
ABBVIE INC. $3.0706/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891010987 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.9706/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955640983 CMS
Merz North America, Inc. $35.3406/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950339291 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.1806/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887675633 CMS
Corcept Therapeutics $15.0105/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948819623 CMS
Novo Nordisk Inc $72.4205/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898555483 CMS
Novo Nordisk Inc $21.2805/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898619267 CMS
Lilly USA, LLC $16.7604/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918131867 CMS
AstraZeneca Pharmaceuticals LP $14.8204/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914753277 CMS
Corcept Therapeutics $17.3604/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948819619 CMS
ABBVIE INC. $17.8404/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891010985 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.5704/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955640981 CMS
AstraZeneca Pharmaceuticals LP $12.4503/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915709617 CMS
ABBVIE INC. $16.0903/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891010983 CMS
Novo Nordisk Inc $20.1603/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898945487 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $697.42 45
PY2020 $462.87 34
PY2021 $606.41 45
PY2022 $1,514.63 68
PY2023 $1,566.78 94
PY2024 $1,681.91 93
PY2025 $1,387.30 78

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $43,373.43 14
PY2024 Principal investigator $171,802.76 70
PY2023 Recipient $23,812.92 7
PY2023 Principal investigator $383,116.06 124
PY2022 Principal investigator $624,521.08 179
PY2021 Principal investigator $663,885.83 360
PY2020 Principal investigator $248,213.43 166
PY2019 Principal investigator $403,386.63 210

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

210 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $5,887.11 12/23/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452103
Principal investigator 1 Novo Nordisk AS $4,892.62 12/19/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452093
Principal investigator 1 Novo Nordisk AS $5,156.40 12/19/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452097
Principal investigator 1 Novo Nordisk AS $2,500.00 12/19/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452101
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704825
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704827
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704829
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704831
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704833
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704835
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704837
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704839
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704841
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704843
Principal investigator 1 Novo Nordisk AS $16.25 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704845
Principal investigator 1 Novo Nordisk AS $103.84 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704847
Principal investigator 1 Novo Nordisk AS $73.20 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704849
Principal investigator 1 Novo Nordisk AS $29.28 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704851
Principal investigator 1 Novo Nordisk AS $119.92 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704853
Principal investigator 1 Novo Nordisk AS $41.60 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704855
Principal investigator 1 Novo Nordisk AS $222.16 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704857
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704859
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704861
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704863
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704865
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704867
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704869
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704871
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704873
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704875
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704877
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704879
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704881
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704883
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704885
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704887
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704889
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704891
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704893
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704895
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704897
Principal investigator 1 Novo Nordisk AS $17.07 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704899
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704905
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704907
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704909
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704911
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705095
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705097
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705099
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705101
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705103
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705105
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705107
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705109
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705111
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705113
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705115
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705117
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705119
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705121
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705123
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705125
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705127
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705129
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705131
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705133
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705135
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705137
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705139
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705141
Principal investigator 1 Novo Nordisk AS $11.38 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705143
Principal investigator 1 Novo Nordisk AS $199.90 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705145
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705147
Principal investigator 1 Novo Nordisk AS $13.50 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705149
Principal investigator 1 Novo Nordisk AS $9.75 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705151
Principal investigator 1 Novo Nordisk AS $90.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705153
Principal investigator 1 Novo Nordisk AS $13.50 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705155
Principal investigator 1 Novo Nordisk AS $74.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705157
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705159
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705161
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705163
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705165
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705167
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705169
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705171
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705173
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705175
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705177
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705179
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705181
Principal investigator 1 Novo Nordisk AS $54.00 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705183
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705185
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705187
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705189
Principal investigator 1 Novo Nordisk AS $9.98 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705191
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705193
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705195
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705197
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705199
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705201
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705203
Principal investigator 1 Novo Nordisk AS $14.97 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705205
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705207
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705209
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705211
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705213
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705215
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705217
Principal investigator 1 Novo Nordisk AS $7.95 12/17/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705219
Principal investigator 1 PFIZER INC. $419.75 12/17/2019 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 948933125
Principal investigator 1 PFIZER INC. $5,377.98 12/17/2019 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 948933131
Principal investigator 1 AbbVie, Inc. $8,487.70 12/10/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613325
Principal investigator 1 Novo Nordisk AS $1,002.96 12/03/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452091
Principal investigator 1 Novo Nordisk AS $3,536.40 12/03/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452095
Principal investigator 1 Novo Nordisk AS $2,152.98 12/03/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452099
Principal investigator 1 AbbVie, Inc. $15,500.70 11/27/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613327
Principal investigator 1 Novo Nordisk AS $24.99 11/27/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706705091
Principal investigator 1 Novo Nordisk AS $67.50 11/07/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705085
Principal investigator 1 Novo Nordisk AS $3,374.57 10/31/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452065
Principal investigator 1 AbbVie, Inc. $1,096.45 10/30/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613323
Principal investigator 1 Novo Nordisk AS $7,660.18 10/29/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452067
Principal investigator 1 Novo Nordisk AS $2,500.00 10/29/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452069
Principal investigator 1 Novo Nordisk AS $1,746.82 10/29/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452071
Principal investigator 1 Novo Nordisk AS $69.18 10/25/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705081
Principal investigator 1 Novo Nordisk AS $69.18 10/22/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705079
Principal investigator 1 Novo Nordisk AS $5.10 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705065
Principal investigator 1 Novo Nordisk AS $49.98 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705067
Principal investigator 1 Novo Nordisk AS $9.00 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705069
Principal investigator 1 Novo Nordisk AS $60.00 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705071
Principal investigator 1 Novo Nordisk AS $6.50 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705073
Principal investigator 1 Novo Nordisk AS $9.80 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705075
Principal investigator 1 Novo Nordisk AS $36.00 10/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705077
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $30.00 10/07/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691589179
Principal investigator 1 AbbVie, Inc. $23,946.75 09/30/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613321
Principal investigator 1 Novo Nordisk AS $250.00 09/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452077
Principal investigator 1 Novo Nordisk AS $4,457.73 09/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452083
Principal investigator 1 Novo Nordisk AS $7,241.45 09/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452089
Principal investigator 1 PFIZER INC. $22,447.82 09/09/2019 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD CO
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662889
Principal investigator 1 PFIZER INC. $4,600.00 09/09/2019 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD CO
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662891
Principal investigator 1 Novo Nordisk AS $800.00 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452073
Principal investigator 1 Novo Nordisk AS $250.00 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 692452075
Principal investigator 1 Novo Nordisk AS $3,000.00 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452079
Principal investigator 1 Novo Nordisk AS $1,000.00 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 692452081
Principal investigator 1 Novo Nordisk AS $5,786.46 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452087
Principal investigator 1 Novo Nordisk AS $69.18 08/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705059
Principal investigator 1 Novo Nordisk AS $10.40 08/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706705031
Principal investigator 1 Novo Nordisk AS $69.18 08/22/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706705029
Principal investigator 1 AbbVie, Inc. $4,551.80 08/20/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613319
Principal investigator 1 Novo Nordisk AS $1.08 08/15/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706705027
Principal investigator 1 Novo Nordisk AS $11,220.92 07/30/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452085
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $1,000.00 07/22/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691588821
Principal investigator 1 AbbVie, Inc. $1,168.75 07/15/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613317
Principal investigator 1 Novo Nordisk AS $22.97 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704815
Principal investigator 1 Novo Nordisk AS $3.05 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704963
Principal investigator 1 Novo Nordisk AS $1.08 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704965
Principal investigator 1 Novo Nordisk AS $79.96 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704967
Principal investigator 1 Novo Nordisk AS $22.76 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704969
Principal investigator 1 Novo Nordisk AS $5.70 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704971
Principal investigator 1 Novo Nordisk AS $4.80 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704973
Principal investigator 1 Novo Nordisk AS $5.10 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704975
Principal investigator 1 Novo Nordisk AS $49.98 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704977
Principal investigator 1 Novo Nordisk AS $9.00 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704979
Principal investigator 1 Novo Nordisk AS $60.00 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704981
Principal investigator 1 Novo Nordisk AS $6.50 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704983
Principal investigator 1 Novo Nordisk AS $9.80 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704985
Principal investigator 1 Novo Nordisk AS $36.00 06/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704987
Principal investigator 1 Novo Nordisk AS $8,838.49 06/25/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452063
Principal investigator 1 AbbVie, Inc. $17,706.70 06/20/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613315
Principal investigator 1 Novo Nordisk AS $117.90 06/20/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 706704817
Principal investigator 1 Novo Nordisk AS $3.05 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704943
Principal investigator 1 Novo Nordisk AS $5.36 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704945
Principal investigator 1 Novo Nordisk AS $4.99 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704947
Principal investigator 1 Novo Nordisk AS $5.30 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704949
Principal investigator 1 Novo Nordisk AS $49.98 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704951
Principal investigator 1 Novo Nordisk AS $9.00 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704953
Principal investigator 1 Novo Nordisk AS $60.00 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704955
Principal investigator 1 Novo Nordisk AS $6.50 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704957
Principal investigator 1 Novo Nordisk AS $9.00 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704959
Principal investigator 1 Novo Nordisk AS $36.00 06/18/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 706704961
Principal investigator 1 Novo Nordisk AS $5,562.95 05/28/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452061
Principal investigator 1 AbbVie, Inc. $27,136.75 05/16/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613313
Principal investigator 1 Novo Nordisk AS $7,778.53 04/25/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452059
Principal investigator 1 AbbVie, Inc. $1,105.00 04/16/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613311
Principal investigator 1 Novo Nordisk AS $1,000.00 04/11/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4270 No dispute reported 06/30/2026 692452049
Principal investigator 1 Novo Nordisk AS $3,250.00 04/11/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4270 No dispute reported 06/30/2026 692452051
Principal investigator 1 Novo Nordisk AS $24.99 04/10/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704919
Principal investigator 1 Novo Nordisk AS $10,077.85 03/28/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4270 No dispute reported 06/30/2026 692452047
Principal investigator 1 Novo Nordisk AS $12,978.20 03/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452057
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $1,000.00 03/25/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691581293
Principal investigator 1 AbbVie, Inc. $7,970.10 03/22/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613307
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $700.00 03/18/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691581267
Principal investigator 1 AbbVie, Inc. $2,195.10 03/15/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613305
Principal investigator 1 Novo Nordisk AS $24.99 03/11/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704917
Principal investigator 1 Novo Nordisk AS $24.99 03/05/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704915
Principal investigator 1 PFIZER INC. $8,171.55 02/27/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662471
Principal investigator 1 PFIZER INC. $19,125.45 02/27/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662813
Principal investigator 1 PFIZER INC. $15,292.80 02/27/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662815
Principal investigator 1 PFIZER INC. $19,219.95 02/27/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A PHASE 3 RANDOMIZED DOUBLEBLIND ACTIVECONTROLLED MULTICENTER STUDY OF THE LONGTERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE No dispute reported 06/30/2026 671662817
Principal investigator 1 Novo Nordisk AS $3,744.90 02/26/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452055
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $6,600.00 02/18/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week randomized, open-label, active-controlled, 2-treatment arm, parallel group multi-center study, comparing the efficacy and safety of Soliqua 100/33 versus Lantus in ethnically/racially divers No dispute reported 06/30/2026 691567803
Principal investigator 1 AbbVie, Inc. $13,000.00 02/14/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613303
Principal investigator 1 Novo Nordisk AS $1.70 02/11/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704913
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $5,823.00 02/04/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week randomized, open-label, active-controlled, 2-treatment arm, parallel group multi-center study, comparing the efficacy and safety of Soliqua 100/33 versus Lantus in ethnically/racially divers No dispute reported 06/30/2026 691567424
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $1,003.00 02/04/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd Co
A 26-week randomized, open-label, active-controlled, 2-treatment arm, parallel group multi-center study, comparing the efficacy and safety of Soliqua 100/33 versus Lantus in ethnically/racially divers No dispute reported 06/30/2026 691610173
Principal investigator 1 Novo Nordisk AS $56.90 01/31/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704821
Principal investigator 1 Novo Nordisk AS $32.50 01/31/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 706704823
Principal investigator 1 Novo Nordisk AS $200.00 01/24/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4270 No dispute reported 06/30/2026 692452043
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4270 No dispute reported 06/30/2026 692452045
Principal investigator 1 Novo Nordisk AS $2,461.45 01/24/2019 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 692452053
Principal investigator 1 AbbVie, Inc. $33,841.85 01/18/2019 Non-covered Recipient Entity
Victorium Clinical Research Ltd
M16-100 No dispute reported 06/30/2026 647613309